10 comments
8 forecasters

What will Biogen’s first public top-line statement about the Phase 2 CELIA trial be by August 12, 2026?

Biogen states CELIA met its primary endpoint13.5%
Biogen states CELIA did not meet its primary endpoint and no positive trend23.2%
Biogen states CELIA did not meet its primary endpoint but showed a positive clinical trendresult: Yes
Biogen releases top-line CELIA data by August 12, 2026 but does not clearly state whether the primary endpoint was met5.3%
No top-line CELIA result is publicly released by August 12, 202627.1%